Nonobstructive CAD: Recognition needed, treatment options sought
Enrollment begins for study evaluating branch thoracic stent graft system
Lipid Forum II Highlights
Antiplatelet Therapy in ACS and PCI
Medtronic announced that it has begun enrollment for a feasibility study assessing the safety and efficacy of a branch thoracic stent graft system.
The Valiant Mona LSA system is an investigational device intended as a fully endovascular treatment for aortic aneurysms encroaching on the left subclavian artery (LSA), according to a company press release. The trial will include 24 patients collected from up to seven facilities throughout the United States, with safety and efficacy evaluated acutely and at 30 days after implantation.
This activity is supported by an educational grant from Eisai, Inc. and Vivus, Inc.
This activity is supported by an educational grant from Amgen, Inc.
The role of lipid-lowering therapies: A look at the guidelines
Nathaniel Reichek, MD: A pioneer in the development of cardiac MRI
This feature offers timely executive summaries of the most relevant journals in cardiology.
Snapshot summaries of recent study results in cardiology.
Your central portal for information presented at ACC 2015.
Your resource for news and videos from SCAI 2014.
This exclusive Healio resource provides you a comprehensive window into what your colleagues and key opinion leaders are saying about current and future drugs and devices and their impact on patient outcomes.
Related story »
View past polls »
Search Healio's robust listing of national and international medical meetings.
©2015 All Rights Reserved.